Rising statin use and effect on ischemic stroke outcome (Q24792305)

1

0 references

James Dambrosia

2

0 references

Julio Chalela

3

0 references

Mustapha Ezzeddine

4

0 references

Steven Warach

5

0 references

Joseph Haymore

6

0 references

Lisa Davis

7

0 references

Alison E Baird

https://scigraph.springernature.com/pub.10.1186/1741-7015-2-4

8

0 references

language of work or name

English

0 references

publication date

23 March 2004

0 references

published in

BMC Medicine

0 references

volume

2

0 references

issue

1

0 references

page(s)

4

0 references

exact match

0 references

cites work

Early statin initiation and outcomes in patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Disparity between angiographic regression and clinical event rates with hydrophobic statins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Direct vascular effects of HMG-CoA reductase inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Interobserver agreement for the assessment of handicap in stroke patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=395844

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

28 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Withdrawal of statin treatment abrogates stroke protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Measurements of acute cerebral infarction: a clinical examination scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Early statin treatment following acute myocardial infarction and 1-year survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-2-4

Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15035663

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15035663